Literature DB >> 10642852

Methamphetamine administration causes overexpression of nNOS in the mouse striatum.

X Deng1, J L Cadet.   

Abstract

The accumulated evidence suggests that the overproduction of nitric oxide (NO) is involved in methamphetamine (METH)-induced neurotoxicity. Using NADPH-diaphorase histochemistry, neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS) antibody immunohistochemistry, the possible overexpression of nNOS and iNOS was investigated in the brains of mice treated with METH. The number of positive cells or the density of positive fibers was assessed at 1 h, 24 h and 1 week after METH injections. There were no clear positive iNOS cells and fibers demonstrated in the brains of mice after METH treatment. In contrast, METH caused marked increases in nNOS in the striatum and hippocampus at 1 and 24 h post-treatment. The nNOS expression normalized by 1 week. There were no statistical changes in nNOS expression in the frontal cortex, the cerebellar cortex, nor in the substantia nigra. These results provide further support for the idea that NO is involved in the neurotoxic effects of METH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10642852     DOI: 10.1016/s0006-8993(99)02087-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor.

Authors:  Esther O'Shea; Veronica Sanchez; Jorge Camarero; A Richard Green; M Isabel Colado
Journal:  Psychopharmacology (Berl)       Date:  2002-11-30       Impact factor: 4.530

2.  Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telithromycin consumption.

Authors:  Elena Cardaioli; Paola Da Pozzo; Gian Nicola Gallus; Rossella Franceschini; Alessandra Rufa; Maria Teresa Dotti; Aldo Caporossi; Antonio Federico
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

3.  Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity.

Authors:  Giulia Costa; Micaela Morelli; Nicola Simola
Journal:  Neurotox Res       Date:  2018-04-09       Impact factor: 3.911

4.  Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity.

Authors:  Danielle M Friend; Jong H Son; Kristen A Keefe; Ashley N Fricks-Gleason
Journal:  J Pharmacol Exp Ther       Date:  2012-12-10       Impact factor: 4.030

5.  Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum.

Authors:  Nathalie Thiriet; Xiaolin Deng; Marcello Solinas; Bruce Ladenheim; Wendy Curtis; Steven R Goldberg; Richard D Palmiter; Jean Lud Cadet
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 6.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

7.  The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.

Authors:  Lauriaselle Afanador; Ina Mexhitaj; Carolyn Diaz; Dalila Ordonez; Lisa Baker; Jesus A Angulo
Journal:  Brain Res       Date:  2013-03-19       Impact factor: 3.252

Review 8.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

Review 9.  Molecular bases of methamphetamine-induced neurodegeneration.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

10.  Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Authors:  Noelia Granado; Sara Ares-Santos; Esther O'Shea; Carlos Vicario-Abejón; M Isabel Colado; Rosario Moratalla
Journal:  Neurotox Res       Date:  2009-09-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.